STOCK TITAN

REVIVA PHARMA HLDGS INC (RVPH) Net Income by Year

RVPH

REVIVA PHARMA HLDGS INC reported a net loss of $19.9M in fiscal year 2025. This represents an increase of 33.6% from the prior fiscal year. The table below carries 8 fiscal years, from 2019 to 2025, and the quarters REVIVA PHARMA HLDGS INC has filed alongside them.

FY2025 annual
Net Income -$19.9M
YoY +33.6%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

RVPH Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1910-K
Net Income-$19.9M+33.6%-$29.9M+23.8%-$39.3M-38.9%-$28.3M-231.6%-$8.5M-125.2%-$3.8MN/A$574K

RVPH Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Net Income-$2.4M+59.6%-$3.2M+50.3%N/A-$4.0M+52.1%-$6.1M+23.0%-$6.4M+13.5%N/A-$8.4M+26.3%-$7.9M+32.9%-$7.4M-8.5%N/A-$11.3M-108.2%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More REVIVA PHARMA HLDGS INC financials

Frequently Asked Questions

What was REVIVA PHARMA HLDGS INC's net income in fiscal year 2025?

REVIVA PHARMA HLDGS INC reported a net loss of $19.9M in fiscal year 2025.

How fast is REVIVA PHARMA HLDGS INC's net income growing?

REVIVA PHARMA HLDGS INC (RVPH) net income rose by 33.6% year over year, from -$29.9M to -$19.9M in fiscal year 2025.

How has REVIVA PHARMA HLDGS INC's net income changed over the years?

Across the 8 fiscal years this page covers, REVIVA PHARMA HLDGS INC (RVPH) net income went from $574K in fiscal year 2019 to -$19.9M in fiscal year 2025.

REVIVA PHARMA HLDGS INC (RVPH) reported -$2.4M in net income in Q2 2026. This represents an increase of 59.6% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what REVIVA PHARMA HLDGS INC (RVPH) reported on that line in every period on record.